Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | ALKS |
---|---|---|
09:32 ET | 293559 | 28.41 |
09:34 ET | 491 | 28.29 |
09:36 ET | 228 | 28.34 |
09:38 ET | 713 | 28.44 |
09:39 ET | 2823 | 28.54 |
09:41 ET | 1031 | 28.495 |
09:43 ET | 1910 | 28.55 |
09:45 ET | 1914 | 28.57 |
09:48 ET | 1020 | 28.545 |
09:50 ET | 600 | 28.525 |
09:52 ET | 4000 | 28.48 |
09:54 ET | 7058 | 28.47 |
09:56 ET | 1902 | 28.43 |
09:57 ET | 300 | 28.43 |
09:59 ET | 4161 | 28.445 |
10:01 ET | 1553 | 28.45 |
10:03 ET | 1422 | 28.46 |
10:06 ET | 9617 | 28.43 |
10:08 ET | 2646 | 28.49 |
10:10 ET | 2412 | 28.54 |
10:12 ET | 2000 | 28.52 |
10:14 ET | 600 | 28.5123 |
10:15 ET | 2060 | 28.54 |
10:17 ET | 2718 | 28.6 |
10:19 ET | 1200 | 28.64 |
10:21 ET | 2618 | 28.665 |
10:24 ET | 719 | 28.7 |
10:26 ET | 4594 | 28.69 |
10:28 ET | 2933 | 28.71 |
10:30 ET | 1708 | 28.675 |
10:32 ET | 1536 | 28.63 |
10:33 ET | 6046 | 28.58 |
10:35 ET | 5220 | 28.58 |
10:37 ET | 2643 | 28.61 |
10:39 ET | 113 | 28.62 |
10:42 ET | 1533 | 28.63 |
10:44 ET | 1200 | 28.655 |
10:46 ET | 1800 | 28.63 |
10:48 ET | 811 | 28.67 |
10:50 ET | 2110 | 28.665 |
10:51 ET | 1000 | 28.64 |
10:53 ET | 1000 | 28.62 |
10:55 ET | 2345 | 28.63 |
10:57 ET | 1263 | 28.64 |
11:00 ET | 600 | 28.63 |
11:02 ET | 717 | 28.61 |
11:04 ET | 700 | 28.59 |
11:06 ET | 2670 | 28.66 |
11:08 ET | 595 | 28.67 |
11:09 ET | 11357 | 28.66 |
11:11 ET | 1347 | 28.57 |
11:13 ET | 20606 | 28.57 |
11:15 ET | 8900 | 28.54 |
11:18 ET | 1100 | 28.51 |
11:20 ET | 700 | 28.529 |
11:22 ET | 2744 | 28.5171 |
11:24 ET | 2261 | 28.5 |
11:26 ET | 900 | 28.5 |
11:27 ET | 1826 | 28.51 |
11:29 ET | 716 | 28.5 |
11:31 ET | 1912 | 28.5 |
11:33 ET | 8640 | 28.51 |
11:36 ET | 3418 | 28.545 |
11:38 ET | 2145 | 28.625 |
11:40 ET | 1050 | 28.66 |
11:42 ET | 1327 | 28.65 |
11:44 ET | 5372 | 28.65 |
11:45 ET | 800 | 28.68 |
11:47 ET | 1409 | 28.68 |
11:49 ET | 9600 | 28.68 |
11:51 ET | 1243 | 28.66 |
11:54 ET | 2600 | 28.65 |
11:56 ET | 1057 | 28.64 |
11:58 ET | 1116 | 28.64 |
12:00 ET | 400 | 28.63 |
12:02 ET | 9409 | 28.63 |
12:03 ET | 900 | 28.63 |
12:05 ET | 15010 | 28.66 |
12:07 ET | 4402 | 28.66 |
12:09 ET | 1931 | 28.64 |
12:12 ET | 1677 | 28.67 |
12:14 ET | 1400 | 28.66 |
12:16 ET | 1200 | 28.65 |
12:18 ET | 1321 | 28.65 |
12:20 ET | 905 | 28.65 |
12:21 ET | 1191 | 28.65 |
12:23 ET | 2302 | 28.675 |
12:25 ET | 900 | 28.68 |
12:27 ET | 3467 | 28.72 |
12:30 ET | 3040 | 28.7 |
12:32 ET | 2607 | 28.68 |
12:34 ET | 912 | 28.68 |
12:36 ET | 2260 | 28.7 |
12:38 ET | 6516 | 28.75 |
12:39 ET | 8310 | 28.8 |
12:41 ET | 1120 | 28.815 |
12:43 ET | 760 | 28.829 |
12:45 ET | 1300 | 28.83 |
12:48 ET | 2740 | 28.85 |
12:50 ET | 1490 | 28.87 |
12:52 ET | 839 | 28.87 |
12:54 ET | 4825 | 28.87 |
12:56 ET | 1757 | 28.909 |
12:57 ET | 1528 | 28.91 |
12:59 ET | 1600 | 28.875 |
01:01 ET | 908 | 28.87 |
01:03 ET | 933 | 28.88 |
01:06 ET | 1882 | 28.85 |
01:08 ET | 1356 | 28.87 |
01:10 ET | 3452 | 28.909 |
01:12 ET | 1000 | 28.89 |
01:14 ET | 1596 | 28.89 |
01:15 ET | 3270 | 28.9 |
01:17 ET | 2875 | 28.91 |
01:19 ET | 5098 | 28.97 |
01:21 ET | 17672 | 29 |
01:24 ET | 13781 | 29 |
01:26 ET | 1732 | 29 |
01:28 ET | 8587 | 29 |
01:30 ET | 6551 | 29.005 |
01:32 ET | 30244 | 28.89 |
01:33 ET | 10517 | 28.85 |
01:35 ET | 2940 | 28.84 |
01:37 ET | 6921 | 28.83 |
01:39 ET | 21362 | 28.81 |
01:42 ET | 900 | 28.745 |
01:44 ET | 2017 | 28.78 |
01:46 ET | 500 | 28.77 |
01:48 ET | 1762 | 28.73 |
01:50 ET | 1440 | 28.72 |
01:51 ET | 851 | 28.745 |
01:53 ET | 1164 | 28.75 |
01:55 ET | 2340 | 28.73 |
01:57 ET | 1134 | 28.72 |
02:00 ET | 857 | 28.75 |
02:02 ET | 923 | 28.72 |
02:04 ET | 2209 | 28.72 |
02:06 ET | 2488 | 28.7 |
02:08 ET | 1364 | 28.69 |
02:09 ET | 4092 | 28.72 |
02:11 ET | 3870 | 28.65 |
02:13 ET | 2423 | 28.649 |
02:15 ET | 2230 | 28.66 |
02:18 ET | 604 | 28.66 |
02:20 ET | 8807 | 28.67 |
02:22 ET | 3956 | 28.62 |
02:24 ET | 2821 | 28.61 |
02:26 ET | 2966 | 28.62 |
02:27 ET | 1634 | 28.635 |
02:29 ET | 771 | 28.63 |
02:31 ET | 4818 | 28.62 |
02:33 ET | 1214 | 28.63 |
02:36 ET | 1491 | 28.619 |
02:38 ET | 2343 | 28.58 |
02:40 ET | 2518 | 28.56 |
02:42 ET | 3008 | 28.57 |
02:44 ET | 2308 | 28.59 |
02:45 ET | 457 | 28.57 |
02:47 ET | 4348 | 28.59 |
02:49 ET | 2465 | 28.59 |
02:51 ET | 2000 | 28.57 |
02:54 ET | 3281 | 28.58 |
02:56 ET | 3292 | 28.58 |
02:58 ET | 4361 | 28.55 |
03:00 ET | 3059 | 28.55 |
03:02 ET | 5965 | 28.55 |
03:03 ET | 4744 | 28.59 |
03:05 ET | 4028 | 28.55 |
03:07 ET | 4766 | 28.56 |
03:09 ET | 6799 | 28.5198 |
03:12 ET | 6400 | 28.53 |
03:14 ET | 5181 | 28.52 |
03:16 ET | 6322 | 28.56 |
03:18 ET | 9223 | 28.56 |
03:20 ET | 3998 | 28.605 |
03:21 ET | 1841 | 28.59 |
03:23 ET | 7185 | 28.6 |
03:25 ET | 9432 | 28.59 |
03:27 ET | 5767 | 28.619 |
03:30 ET | 8286 | 28.65 |
03:32 ET | 8062 | 28.675 |
03:34 ET | 3218 | 28.66 |
03:36 ET | 5322 | 28.68 |
03:38 ET | 24544 | 28.65 |
03:39 ET | 7152 | 28.7 |
03:41 ET | 8171 | 28.69 |
03:43 ET | 4863 | 28.67 |
03:45 ET | 5626 | 28.67 |
03:48 ET | 7710 | 28.615 |
03:50 ET | 8912 | 28.59 |
03:52 ET | 52211 | 28.46 |
03:54 ET | 29772 | 28.495 |
03:56 ET | 35736 | 28.55 |
03:57 ET | 35133 | 28.57 |
03:59 ET | 4156464 | 28.55 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Alkermes Plc | 4.7B | 10.7x | --- |
Exelixis Inc | 7.5B | 22.6x | -21.77% |
PTC Therapeutics Inc | 2.8B | -5.8x | --- |
P3 Health Partners Inc | 153.8M | -0.7x | --- |
Novavax Inc | 2.1B | -4.7x | --- |
Qiagen NV | 10.1B | 141.1x | +12.66% |
Alkermes plc is a global biopharmaceutical company that seeks to develop medicines in the field of neuroscience. The Company has a portfolio of commercial products for the treatment of alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder and a pipeline of clinical and preclinical candidates in development for neurological disorders. It focuses on commercial products, such as LYBALVI, ARISTADA/ARISTADA INITIO and VIVITROL, and advancing the development of pipeline programs focused on neurological disorders. LYBALVI is a once-daily, oral atypical antipsychotic drug for the treatment of adults with schizophrenia and for the treatment of adults with bipolar I disorder, as a maintenance monotherapy or for the acute treatment of manic or mixed episodes, as monotherapy or an adjunct to lithium or valproate. ARISTADA is an extended-release intramuscular injectable suspension for the treatment of schizophrenia. It has a manufacturing facility in Wilmington, Ohio.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $4.7B |
---|---|
Revenue (TTM) | $1.5B |
Shares Outstanding | 164.7M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.42 |
EPS | $2.67 |
Book Value | $7.20 |
P/E Ratio | 10.7x |
Price/Sales (TTM) | 3.1 |
Price/Cash Flow (TTM) | 9.2x |
Operating Margin | 24.91% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.